I was more sending it in the context of the recent discussions of aspirin and metformin.
From discussions I have [/was given] the same a priori as you (if not cognitive impairments, at least ‘reduced energy’ in many cases; mild myopathies for 1 in 10 persons; I thought headaches were light and temporary, but it doesn’t change the whole picture)
De : Sheldon Ball À : Edouard Debonneuil ; Gerontology Research Group Envoyé le : Mercredi 13 août 2014 17h14Objet : Re: [GRG] Statins, human geroprotector?
Hi Edouard,Let’s put this into perspective. see [1,2]… and before you go munch on a statin, review your prioritiesThe second most common complaint of patients on statins is memory loss (after myalgias)
While no clear association of memory impairment with statin use has been established,no study has examined the effect of statins on intense mental activity.That is do statins make you smarter ?1. http://ift.tt/1usunQx
On Wed, Aug 13, 2014 at 7:22 AM, Edouard Debonneuil wrote:
Following the controversy of credentials of aspirin and metformin as human geroprotectors…
…I thought it would be interesting to post about statins:
“the statin drug rosuvastatin (Crestor) slashed the rate of heart attacks and strokes in people with normal LDL cholesterol who had elevated levels of C-reactive protein (CRP). CRP is a marker of inflammation, and there is increasing evidence that low-grade inflammation raises heart risk.”
Potential caveats explained below (2y study, relatively high dose…). Next on GRG, a similar study with nebivolol? 😉